Walleye Trading
LKFT

Walleye Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Walleye Trading’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-200
Closed -$12K – 5331
2022
Q1 		$12K Buy
+200
New +$12.2K ﹤0.01% 4896
2020
Q4 		– Sell
-2,700
Closed -$383K – 4709
2020
Q3 		$383K Buy
+2,700
New +$450K ﹤0.01% 2476

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Walleye Trading's LKFT Position: Q3 2020 in Review

Walleye Trading sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 1,500 shares — an estimated $250K sold.

Walleye Trading first reported a position in LKFT in Q3 2015 and held it in 5 quarters. The position peaked at $296K in Q2 2020. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

  • Walleye Trading reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Walleye Trading sold 1,500 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $250K.
  • Walleye Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 5 quarters.
  • Walleye Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $296K in Q2 2020.
  • 119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Walleye Trading's 13F filing for Q3 2020, filed 16 Nov 2020.